Bornstein Yoseph 4
4 · Microbot Medical Inc. · Filed Dec 21, 2017
Insider Transaction Report
Form 4
Bornstein Yoseph
Director10% Owner
Transactions
- Sale
Common Stock
2017-12-20$1.03/sh−12,933$13,329→ 4,655,409 total(indirect: By LSA- LifeScience Accelerator Ltd.) - Sale
Common Stock
2017-12-19$1.03/sh−32,067$33,029→ 4,655,409 total(indirect: By LSA- LifeScience Accelerator Ltd.)
Footnotes (2)
- [F1]Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 45,000 shares of Issuer common stock on December 19, 2017 and December 20, 2017. Accordingly, Reporting Person beneficially owned 4,655,409 shares of Issuer common stock following the reported transactions.
- [F2]Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. ("LSA") and of Shizim Ltd. ("Shizim"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities.